DOXYCYCLINE

DOXYCYCLINE was reported 69432 times

DOXYCYCLINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 61 0.8714
1 GRIP STRENGTH 143 0.6245
2 CONGENITAL HIATUS HERNIA 118 0.5175
3 C-REACTIVE PROTEIN 470 0.5070
4 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 300 0.4491
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 898 0.4483
6 SWOLLEN JOINT COUNT 112 0.4480
7 JARISCH-HERXHEIMER REACTION 313 0.4396
8 LUPUS VULGARIS 532 0.4222
9 GASTROINTESTINAL MUCOSAL NECROSIS 55 0.3793
10 SWOLLEN JOINT COUNT INCREASED 1044 0.3271
11 ABORTION INCOMPLETE 553 0.2968
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 535 0.2580
13 RHEUMATIC FEVER 1134 0.2541
14 RETINITIS 428 0.2475
15 FACET JOINT SYNDROME 745 0.2286
16 DISLOCATION OF VERTEBRA 486 0.2129
17 X-RAY ABNORMAL 380 0.2123
18 RHEUMATOID FACTOR POSITIVE 1216 0.2103
19 OVERLAP SYNDROME 126 0.1800
20 DUODENAL ULCER PERFORATION 1277 0.1715
21 SERONEGATIVE ARTHRITIS 177 0.1545
22 BONE EROSION 522 0.1475
23 C-REACTIVE PROTEIN ABNORMAL 946 0.1473
24 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 913 0.1404
25 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 953 0.1329
26 HELICOBACTER INFECTION 1332 0.1295
27 PORPHYRIA ACUTE 179 0.1247
28 FOLLICULITIS 1243 0.1184
29 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 120 0.1130
30 MUSCLE INJURY 911 0.1098
31 PERIPHERAL VENOUS DISEASE 416 0.1018
32 HAND DEFORMITY 1318 0.1004
33 AUTOIMMUNE DISORDER 923 0.0946
34 DRUG TOLERANCE DECREASED 257 0.0914
35 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 51 0.0909
36 LIP DRY 822 0.0904
37 HYPERPARATHYROIDISM SECONDARY 224 0.0893
38 NEPHROGENIC ANAEMIA 405 0.0873
39 REBOUND ACID HYPERSECRETION 263 0.0869
40 GRANULOMA SKIN 71 0.0865
41 ENDOMETRITIS 56 0.0842
42 PEMPHIGUS 1047 0.0837
43 FIXED ERUPTION 141 0.0819
44 BREAST CANCER STAGE III 497 0.0767
45 HYPERCHOLESTEROLAEMIA 725 0.0750
46 SYNOVITIS 1344 0.0745
47 JOINT RANGE OF MOTION DECREASED 967 0.0720
48 SCIATICA 1127 0.0706
49 MALIGNANT MELANOMA IN SITU 87 0.0702
50 GRIP STRENGTH DECREASED 578 0.0656
51 PERICARDITIS 1083 0.0644
52 WOUND INFECTION 698 0.0637
53 GLOSSODYNIA 1395 0.0622
54 CHOLANGITIS SCLEROSING 126 0.0613
55 EXOSTOSIS 544 0.0595
56 IRRITABLE BOWEL SYNDROME 1223 0.0570
57 FIBROMYALGIA 1369 0.0563
58 BURSITIS 652 0.0537
59 LUPUS-LIKE SYNDROME 482 0.0531
60 LIVE BIRTH 440 0.0525
61 LYME DISEASE 175 0.0524
62 BREATH SOUNDS ABNORMAL 255 0.0517
63 RED BLOOD CELL SEDIMENTATION RATE INCREASED 560 0.0506
64 WOUND 1402 0.0501
65 WALKING AID USER 323 0.0489
66 PELVIC INFLAMMATORY DISEASE 72 0.0482
67 LOWER LIMB FRACTURE 917 0.0477
68 ASPERGILLUS INFECTION 311 0.0473
69 BLOOD PARATHYROID HORMONE DECREASED 70 0.0472
70 MATERNAL EXPOSURE TIMING UNSPECIFIED 175 0.0465
71 OESOPHAGEAL ULCER 176 0.0457
72 JOINT DISLOCATION 472 0.0446
73 GASTROINTESTINAL INJURY 118 0.0438
74 END STAGE RENAL DISEASE 796 0.0436
75 LIVER INJURY 1058 0.0431
76 FOOT DEFORMITY 474 0.0427
77 BRONCHIAL HYPERREACTIVITY 51 0.0424
78 IMPAIRED HEALING 1362 0.0414
79 HIDRADENITIS 375 0.0411
80 TYPE 2 DIABETES MELLITUS 1363 0.0404
81 ROSACEA 188 0.0403
82 OBESITY 615 0.0386
83 SYSTEMIC LUPUS ERYTHEMATOSUS 1370 0.0386
84 PULMONARY FIBROSIS 696 0.0362
85 PRESCRIBED OVERDOSE 699 0.0361
86 CHRONIC KIDNEY DISEASE 2633 0.0346
87 PULMONARY FUNCTION TEST ABNORMAL 53 0.0340
88 PANNICULITIS 79 0.0326
89 HIP ARTHROPLASTY 497 0.0324
90 CONTRAINDICATED PRODUCT ADMINISTERED 973 0.0321
91 METHAEMOGLOBINAEMIA 74 0.0319
92 PSORIATIC ARTHROPATHY 1297 0.0319
93 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 78 0.0315
94 INFUSION SITE DISCHARGE 55 0.0313
95 PRESCRIBED UNDERDOSE 618 0.0309
96 CHOLESTATIC LIVER INJURY 68 0.0305
97 WHEEZING 1798 0.0303
98 SPONDYLITIS 110 0.0302
99 HEPATIC CIRRHOSIS 565 0.0300
100 BENIGN PROSTATIC HYPERPLASIA 153 0.0296
101 DERMATITIS ACNEIFORM 178 0.0292
102 PULMONARY PAIN 85 0.0291
103 RHEUMATOID NODULE 79 0.0287
104 LOWER RESPIRATORY TRACT INFECTION 1295 0.0284
105 BRONCHIECTASIS 191 0.0283
106 OESOPHAGITIS 308 0.0282
107 ONYCHOMADESIS 118 0.0281
108 ROAD TRAFFIC ACCIDENT 1144 0.0273
109 PREGNANCY 545 0.0272
110 BLISTER 1507 0.0268
111 IDIOPATHIC INTRACRANIAL HYPERTENSION 60 0.0267
112 OSTEOARTHRITIS 1120 0.0264
113 PHOTOSENSITIVITY REACTION 435 0.0263
114 GAIT INABILITY 877 0.0262
115 CYTOPENIA 320 0.0261
116 INTRACRANIAL PRESSURE INCREASED 140 0.0251
117 BLOOD CHOLESTEROL INCREASED 1171 0.0251
118 PUSTULE 59 0.0249
119 SPINAL FUSION SURGERY 101 0.0249
120 EAR INFECTION 652 0.0245
121 KNEE ARTHROPLASTY 514 0.0244
122 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 406 0.0239
123 ARTHROPATHY 1304 0.0234
124 INFUSION SITE REACTION 70 0.0234
125 INJURY 1636 0.0233
126 INFUSION RELATED REACTION 1537 0.0232
127 HEPATIC ENZYME INCREASED 1577 0.0231
128 NIGHT SWEATS 736 0.0228
129 ULCER HAEMORRHAGE 153 0.0226
130 LUNG CONSOLIDATION 63 0.0225
131 LIVER DISORDER 988 0.0223
132 TUBULOINTERSTITIAL NEPHRITIS 417 0.0222
133 STOMATITIS 1337 0.0220
134 OEDEMA 1181 0.0218
135 TACHYARRHYTHMIA 54 0.0216
136 ISCHAEMIC CARDIOMYOPATHY 65 0.0212
137 JOINT STIFFNESS 554 0.0211
138 SINUSITIS 2156 0.0210
139 MOBILITY DECREASED 1509 0.0210
140 BLEPHAROSPASM 132 0.0209
141 PEMPHIGOID 158 0.0209
142 EYE INJURY 63 0.0207
143 DRUG TOLERANCE 102 0.0201
144 INFLAMMATION 1034 0.0200
145 DISCOMFORT 1212 0.0198
146 PARONYCHIA 87 0.0198
147 DIABETES INSIPIDUS 47 0.0195
148 BREAST CANCER STAGE II 162 0.0195
149 TREATMENT FAILURE 1584 0.0191
150 OSTEOPOROSIS 779 0.0189
151 ECONOMIC PROBLEM 285 0.0188
152 C-REACTIVE PROTEIN INCREASED 682 0.0187
153 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 102 0.0187
154 INFUSION SITE PRURITUS 59 0.0187
155 DELIRIUM 649 0.0187
156 EAR PAIN 361 0.0186
157 BLOOD PRESSURE DIASTOLIC ABNORMAL 47 0.0185
158 LUNG DISORDER 890 0.0181
159 THERAPEUTIC PRODUCT EFFECT DECREASED 809 0.0180
160 DRUG-INDUCED LIVER INJURY 566 0.0180
161 THERAPY NON-RESPONDER 810 0.0180
162 ULCERATIVE KERATITIS 49 0.0179
163 DRUG INTOLERANCE 1691 0.0175
164 NAIL DISORDER 152 0.0174
165 ABSCESS LIMB 74 0.0173
166 SWELLING 1596 0.0170
167 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 814 0.0169
168 SUBCUTANEOUS ABSCESS 81 0.0169
169 INFECTION 2439 0.0168
170 OBSTRUCTIVE AIRWAYS DISORDER 187 0.0168
171 ODYNOPHAGIA 100 0.0167
172 FULL BLOOD COUNT ABNORMAL 176 0.0166
173 MUSCULOSKELETAL STIFFNESS 1455 0.0166
174 PUSTULAR PSORIASIS 57 0.0166
175 PAPILLOEDEMA 74 0.0164
176 ANHEDONIA 428 0.0163
177 UPPER RESPIRATORY TRACT INFECTION 751 0.0162
178 RHEUMATOID ARTHRITIS 1837 0.0162
179 ARTHRITIS INFECTIVE 75 0.0162
180 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 277 0.0161
181 JOINT SWELLING 1948 0.0161
182 TENDERNESS 168 0.0161
183 SLEEP DISORDER 1135 0.0161
184 OESOPHAGEAL PAIN 63 0.0159
185 MUSCULOSKELETAL PAIN 830 0.0158
186 ILL-DEFINED DISORDER 961 0.0158
187 SUSPECTED OFF LABEL USE 71 0.0157
188 HYPERTRANSAMINASAEMIA 109 0.0157
189 ACUTE KIDNEY INJURY 2383 0.0156
190 RASH VESICULAR 75 0.0155
191 INFUSION SITE HAEMORRHAGE 51 0.0155
192 GASTROINTESTINAL DISORDER 1379 0.0154
193 WEIGHT FLUCTUATION 160 0.0153
194 ASTHMA 1722 0.0152
195 SKIN NECROSIS 79 0.0152
196 SUNBURN 113 0.0151
197 MOUTH SWELLING 87 0.0151
198 DRY MOUTH 1223 0.0151
199 RENAL INJURY 447 0.0150
200 CUSHINGOID 48 0.0149
201 RENAL TUBULAR NECROSIS 146 0.0149
202 ARTHROPOD BITE 110 0.0148
203 SKIN INFECTION 164 0.0146
204 MICTURITION URGENCY 166 0.0145
205 LIVER FUNCTION TEST INCREASED 310 0.0144
206 POLYARTHRITIS 76 0.0144
207 DISABILITY 285 0.0144
208 CONTUSION 1385 0.0144
209 PARANASAL SINUS DISCOMFORT 54 0.0143
210 ONYCHOMYCOSIS 62 0.0141
211 CHRONIC SINUSITIS 53 0.0141
212 SEASONAL ALLERGY 199 0.0140
213 CHOLECYSTITIS CHRONIC 94 0.0140
214 INFUSION SITE SWELLING 88 0.0140
215 INFLAMMATORY MARKER INCREASED 69 0.0139
216 PAPULE 98 0.0139
217 INTENTIONAL PRODUCT USE ISSUE 1211 0.0138
218 SPUTUM DISCOLOURED 131 0.0138
219 NORMAL NEWBORN 75 0.0138
220 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 107 0.0138
221 RENAL FAILURE 1821 0.0137
222 PANCREATITIS ACUTE 308 0.0137
223 GENERAL PHYSICAL HEALTH DETERIORATION 1580 0.0136
224 BRONCHITIS 1009 0.0136
225 GASTROOESOPHAGEAL REFLUX DISEASE 1093 0.0136
226 HYPOAESTHESIA 2024 0.0135
227 ORAL CANDIDIASIS 178 0.0135
228 GASTRITIS EROSIVE 63 0.0135
229 HORDEOLUM 58 0.0134
230 AUTOIMMUNE HEPATITIS 91 0.0131
231 ABDOMINAL DISCOMFORT 2185 0.0130
232 WOUND SECRETION 51 0.0130
233 CYSTIC FIBROSIS 72 0.0130
234 MELANOCYTIC NAEVUS 57 0.0130
235 DERMATITIS BULLOUS 93 0.0128
236 DRUG RESISTANCE 328 0.0128
237 HYPERVOLAEMIA 63 0.0127
238 TENDON PAIN 96 0.0127
239 MATERNAL EXPOSURE DURING PREGNANCY 1117 0.0125
240 PRE-EXISTING CONDITION IMPROVED 78 0.0125
241 RALES 72 0.0124
242 MULTIPLE ALLERGIES 97 0.0124
243 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 676 0.0123
244 OSTEOPENIA 186 0.0122
245 HYPERSENSITIVITY 2256 0.0121
246 SKIN ULCER 313 0.0121
247 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 853 0.0120
248 PRODUCT ADMINISTRATION INTERRUPTED 94 0.0120
249 CARDIOMEGALY 147 0.0119
250 RASH PUSTULAR 87 0.0119
251 RESPIRATORY DISORDER 357 0.0119
252 AMNESIA 776 0.0119
253 TOXIC EPIDERMAL NECROLYSIS 181 0.0119
254 UTERINE PERFORATION 100 0.0118
255 PHOTOPHOBIA 222 0.0118
256 PRODUCTIVE COUGH 563 0.0118
257 FOREIGN BODY SENSATION IN EYES 75 0.0118
258 SPINAL OSTEOARTHRITIS 103 0.0117
259 VAGINAL INFECTION 55 0.0117
260 ARTHRITIS 919 0.0117
261 PERIPHERAL SWELLING 1795 0.0116
262 HALLUCINATIONS, MIXED 49 0.0116
263 ULCER 185 0.0116
264 INFUSION SITE ERYTHEMA 98 0.0116
265 FURUNCLE 92 0.0116
266 CYST 144 0.0116
267 LIP SWELLING 386 0.0116
268 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 296 0.0115
269 PERIORBITAL SWELLING 65 0.0115
270 ATELECTASIS 111 0.0115
271 HAEMORRHAGE 1200 0.0115
272 BASAL CELL CARCINOMA 179 0.0115
273 PATHOGEN RESISTANCE 104 0.0114
274 URTICARIA 1901 0.0113
275 DYSPEPSIA 1114 0.0113
276 CELLULITIS 562 0.0111
277 SKIN MASS 74 0.0111
278 RENAL CYST 88 0.0111
279 NEPHROPATHY 103 0.0110
280 VASCULAR DEVICE INFECTION 50 0.0110
281 RHINITIS ALLERGIC 49 0.0110
282 SKIN ABRASION 52 0.0110
283 STAPHYLOCOCCAL INFECTION 361 0.0109
284 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 569 0.0109
285 CANDIDA INFECTION 183 0.0108
286 DRUG ERUPTION 192 0.0108
287 DERMATITIS 227 0.0108
288 INFUSION SITE PAIN 139 0.0108
289 SKIN LESION 295 0.0107
290 STEVENS-JOHNSON SYNDROME 238 0.0107
291 LYMPHOEDEMA 74 0.0107
292 RESPIRATORY TRACT INFECTION 278 0.0107
293 HYPERTENSION 2255 0.0106
294 DERMATITIS CONTACT 121 0.0106
295 MYOSITIS 95 0.0106
296 CLOSTRIDIUM DIFFICILE COLITIS 112 0.0106
297 SWELLING OF EYELID 66 0.0105
298 PSEUDOMONAS INFECTION 90 0.0105
299 INTERVERTEBRAL DISC DEGENERATION 97 0.0105
300 FACIAL PAIN 93 0.0104
301 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 78 0.0104
302 CONFUSIONAL STATE 1674 0.0103
303 HYPOMAGNESAEMIA 144 0.0103
304 NODULE 133 0.0102
305 CHEST PAIN 1885 0.0102
306 SCAR 174 0.0102
307 LOCALISED OEDEMA 47 0.0101
308 SKIN HYPERPIGMENTATION 87 0.0101
309 TASTE DISORDER 205 0.0101
310 CONDITION AGGRAVATED 3072 0.0101
311 EYE PAIN 567 0.0100
312 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 50 0.0100
313 CHEILITIS 54 0.0100
314 LOCALISED INFECTION 240 0.0099
315 FREQUENT BOWEL MOVEMENTS 268 0.0099
316 RASH PRURITIC 537 0.0099
317 PERIPHERAL VASCULAR DISORDER 51 0.0099
318 SKIN PLAQUE 83 0.0098
319 POST PROCEDURAL INFECTION 80 0.0098
320 UPPER-AIRWAY COUGH SYNDROME 81 0.0098
321 RASH 4281 0.0098
322 COLITIS ULCERATIVE 438 0.0098
323 OSTEOMYELITIS 177 0.0098
324 SWOLLEN TONGUE 305 0.0098
325 OEDEMA PERIPHERAL 1187 0.0097
326 SINUS CONGESTION 131 0.0097
327 APPETITE DISORDER 64 0.0096
328 SKIN WARM 56 0.0096
329 NASOPHARYNGITIS 1771 0.0096
330 DYSPNOEA EXERTIONAL 356 0.0094
331 MUSCULOSKELETAL CHEST PAIN 146 0.0094
332 TOOTH ABSCESS 96 0.0094
333 EOSINOPHILIA 164 0.0093
334 ACUTE RESPIRATORY FAILURE 180 0.0093
335 RASH MACULO-PAPULAR 208 0.0093
336 HAEMOPTYSIS 259 0.0093
337 HERPES SIMPLEX 60 0.0092
338 ANXIETY 2622 0.0092
339 THERAPY PARTIAL RESPONDER 143 0.0092
340 BLOOD MAGNESIUM DECREASED 79 0.0091
341 MULTIPLE ORGAN DYSFUNCTION SYNDROME 256 0.0090
342 CLOSTRIDIUM DIFFICILE INFECTION 197 0.0090
343 VITAMIN D DEFICIENCY 88 0.0090
344 WHITE BLOOD CELL COUNT INCREASED 346 0.0090
345 BACK INJURY 98 0.0090
346 ALOPECIA 1766 0.0090
347 JOINT INJURY 192 0.0090
348 MIGRAINE 858 0.0090
349 PANCREATITIS 475 0.0090
350 HEPATITIS 229 0.0089
351 EYE INFECTION 101 0.0089
352 MEDICATION ERROR 496 0.0089
353 CONGENITAL ANOMALY 69 0.0089
354 TENDON DISORDER 58 0.0089
355 MAJOR DEPRESSION 65 0.0089
356 DECREASED APPETITE 2062 0.0089
357 MENORRHAGIA 174 0.0089
358 TENDONITIS 137 0.0088
359 EXPOSURE DURING PREGNANCY 548 0.0088
360 VASCULITIS 102 0.0087
361 GASTRIC ULCER 166 0.0087
362 PULMONARY MASS 130 0.0087
363 PNEUMONIA BACTERIAL 80 0.0087
364 GINGIVITIS 47 0.0087
365 RECTAL HAEMORRHAGE 372 0.0087
366 ABDOMINAL PAIN UPPER 1773 0.0086
367 HYPERCALCAEMIA 106 0.0086
368 PNEUMONIA 2766 0.0085
369 NEUTROPENIC SEPSIS 61 0.0085
370 INFUSION SITE EXTRAVASATION 53 0.0085
371 RIB FRACTURE 175 0.0085
372 ATRIAL FIBRILLATION 825 0.0085
373 TINNITUS 388 0.0084
374 JOINT EFFUSION 58 0.0084
375 CONJUNCTIVITIS 156 0.0084
376 MUSCULAR WEAKNESS 954 0.0084
377 HYPERLIPIDAEMIA 100 0.0084
378 VOMITING 3930 0.0084
379 SLEEP APNOEA SYNDROME 159 0.0083
380 MUSCLE STRAIN 72 0.0083
381 LABORATORY TEST ABNORMAL 245 0.0083
382 SINUS HEADACHE 49 0.0082
383 HEPATIC CYTOLYSIS 105 0.0082
384 INFLAMMATORY BOWEL DISEASE 80 0.0082
385 DIVERTICULUM 58 0.0082
386 PELVIC PAIN 148 0.0081
387 TOOTH INFECTION 107 0.0081
388 SQUAMOUS CELL CARCINOMA OF SKIN 49 0.0081
389 PYREXIA 2804 0.0081
390 SWELLING FACE 526 0.0081
391 CHOLESTASIS 155 0.0081
392 VISUAL IMPAIRMENT 1000 0.0081
393 SINUS DISORDER 159 0.0080
394 ECCHYMOSIS 55 0.0080
395 LEUKOCYTOSIS 145 0.0080
396 QUALITY OF LIFE DECREASED 107 0.0080
397 PHARYNGEAL SWELLING 78 0.0080
398 ARTERIOSCLEROSIS 75 0.0080
399 PRURITUS 3044 0.0079
400 NECK PAIN 441 0.0079
401 THROMBOCYTOPENIA 881 0.0079
402 DENTAL CARIES 87 0.0079
403 MOUTH ULCERATION 165 0.0078
404 DIARRHOEA HAEMORRHAGIC 73 0.0078
405 HYPERAESTHESIA 64 0.0078
406 GASTRITIS 205 0.0078
407 REBOUND EFFECT 88 0.0078
408 PRODUCT USE IN UNAPPROVED INDICATION 1929 0.0078
409 ORAL PAIN 174 0.0078
410 EYE SWELLING 289 0.0078
411 OCULAR DISCOMFORT 87 0.0077
412 DEPRESSION 1760 0.0077
413 SUPRAVENTRICULAR TACHYCARDIA 74 0.0077
414 SCAB 88 0.0077
415 ONYCHOCLASIS 53 0.0077
416 EYE DISCHARGE 80 0.0077
417 WEIGHT INCREASED 1718 0.0077
418 COELIAC DISEASE 75 0.0076
419 PANIC REACTION 55 0.0076
420 ABDOMINAL PAIN 1772 0.0076
421 POST-TRAUMATIC STRESS DISORDER 51 0.0076
422 CARPAL TUNNEL SYNDROME 106 0.0076
423 POSTOPERATIVE WOUND INFECTION 51 0.0075
424 ADVERSE DRUG REACTION 678 0.0075
425 VITREOUS FLOATERS 74 0.0075
426 SKIN REACTION 106 0.0075
427 ABSCESS 120 0.0075
428 GROIN PAIN 66 0.0075
429 MEMORY IMPAIRMENT 1032 0.0075
430 FUNGAL INFECTION 250 0.0075
431 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 66 0.0075
432 LEFT VENTRICULAR DYSFUNCTION 50 0.0075
433 HEPATIC ENCEPHALOPATHY 69 0.0074
434 EPILEPSY 225 0.0074
435 LUNG INFILTRATION 65 0.0074
436 PULMONARY THROMBOSIS 80 0.0073
437 ADRENAL INSUFFICIENCY 89 0.0073
438 DYSPNOEA 4151 0.0073
439 RHINITIS 59 0.0073
440 SKIN FISSURES 143 0.0073
441 SKIN DISORDER 244 0.0073
442 RESPIRATORY TRACT CONGESTION 116 0.0073
443 INCREASED TENDENCY TO BRUISE 67 0.0073
444 BACK DISORDER 118 0.0072
445 FLANK PAIN 68 0.0072
446 ARTERIOSCLEROSIS CORONARY ARTERY 48 0.0072
447 CARDIOMYOPATHY 107 0.0072
448 AORTIC ANEURYSM 55 0.0072
449 SQUAMOUS CELL CARCINOMA 68 0.0072
450 LIGAMENT SPRAIN 71 0.0072
451 MUSCLE SPASMS 1313 0.0071
452 INSOMNIA 1903 0.0071
453 PARAESTHESIA 1122 0.0071
454 JAUNDICE 191 0.0071
455 SKIN LACERATION 77 0.0071
456 BACTERAEMIA 84 0.0071
457 DEAFNESS 185 0.0071
458 CORONARY ARTERY DISEASE 214 0.0071
459 OROPHARYNGEAL PAIN 652 0.0070
460 MALAISE 3079 0.0070
461 BRAIN FOG 110 0.0070
462 PHARYNGITIS 87 0.0070
463 ARTHRALGIA 2913 0.0070
464 FOOD ALLERGY 54 0.0070
465 RASH MACULAR 243 0.0069
466 DUODENAL ULCER 49 0.0069
467 COVID-19 PNEUMONIA 82 0.0069
468 HICCUPS 57 0.0069
469 IRON DEFICIENCY ANAEMIA 64 0.0069
470 TACHYCARDIA 615 0.0069
471 UPPER GASTROINTESTINAL HAEMORRHAGE 116 0.0069
472 TRANSIENT ISCHAEMIC ATTACK 232 0.0069
473 GASTROENTERITIS VIRAL 124 0.0069
474 INSURANCE ISSUE 105 0.0069
475 DYSURIA 252 0.0068
476 FEBRILE NEUTROPENIA 454 0.0068
477 IMMUNODEFICIENCY 102 0.0068
478 ANAEMIA 1305 0.0068
479 INTERNATIONAL NORMALISED RATIO INCREASED 195 0.0068
480 GASTROINTESTINAL INFECTION 61 0.0068
481 BONE DISORDER 124 0.0068
482 HYPOKALAEMIA 314 0.0068
483 PULMONARY TOXICITY 48 0.0068
484 HYPOXIA 239 0.0068
485 PROTEINURIA 129 0.0068
486 RHINORRHOEA 437 0.0068
487 APHTHOUS ULCER 52 0.0067
488 FEELING HOT 411 0.0067
489 PAIN 4111 0.0067
490 PNEUMOCYSTIS JIROVECII PNEUMONIA 67 0.0067
491 GAIT DISTURBANCE 1277 0.0067
492 GINGIVAL PAIN 53 0.0067
493 RASH ERYTHEMATOUS 317 0.0066
494 DERMATITIS ALLERGIC 83 0.0066
495 MYOCARDIAL ISCHAEMIA 75 0.0066
496 DEEP VEIN THROMBOSIS 428 0.0066
497 SMALL INTESTINAL OBSTRUCTION 81 0.0066
498 ESCHERICHIA INFECTION 54 0.0066
499 PURPURA 58 0.0065
500 DIVERTICULITIS 181 0.0065
501 SPINAL COMPRESSION FRACTURE 54 0.0065
502 DRY EYE 326 0.0065
503 LIPASE INCREASED 50 0.0065
504 MASS 91 0.0065
505 BLOOD PRESSURE DIASTOLIC DECREASED 48 0.0065
506 EYE INFLAMMATION 62 0.0065
507 INTERVERTEBRAL DISC PROTRUSION 142 0.0065
508 NAUSEA 5141 0.0065
509 BACTERIAL INFECTION 121 0.0065
510 PHARYNGITIS STREPTOCOCCAL 70 0.0065
511 DIARRHOEA 4166 0.0064
512 MITRAL VALVE INCOMPETENCE 73 0.0064
513 HEADACHE 4040 0.0064
514 EMPHYSEMA 65 0.0064
515 MALNUTRITION 72 0.0064
516 SKIN EXFOLIATION 539 0.0064
517 NEUROPATHY PERIPHERAL 607 0.0064
518 WEIGHT DECREASED 1781 0.0064
519 PARAESTHESIA ORAL 92 0.0064
520 EOSINOPHIL COUNT INCREASED 53 0.0064
521 CARDIAC MURMUR 55 0.0064
522 TOOTH FRACTURE 70 0.0063
523 NEPHROLITHIASIS 291 0.0063
524 DRUG INTERACTION 1006 0.0063
525 HIATUS HERNIA 82 0.0063
526 EAR DISCOMFORT 65 0.0063
527 ACUTE RESPIRATORY DISTRESS SYNDROME 112 0.0063
528 FOOT FRACTURE 120 0.0063
529 BODY TEMPERATURE INCREASED 129 0.0063
530 PRODUCT USE ISSUE 1188 0.0063
531 BLOOD IRON DECREASED 75 0.0063
532 SPLENOMEGALY 74 0.0063
533 DRY THROAT 64 0.0063
534 MUSCULOSKELETAL DISCOMFORT 108 0.0063
535 COUGH 1759 0.0063
536 LIVER FUNCTION TEST ABNORMAL 182 0.0063
537 PAIN IN EXTREMITY 1839 0.0062
538 FATIGUE 4850 0.0062
539 BONE DENSITY DECREASED 195 0.0062
540 HEAD DISCOMFORT 110 0.0062
541 NOCTURIA 75 0.0062
542 THINKING ABNORMAL 115 0.0062
543 CHEST DISCOMFORT 632 0.0062
544 EMOTIONAL DISTRESS 747 0.0062
545 IMPAIRED GASTRIC EMPTYING 84 0.0062
546 RESTLESS LEGS SYNDROME 112 0.0062
547 ILLNESS 633 0.0061
548 HAEMOLYTIC ANAEMIA 55 0.0061
549 FISTULA 69 0.0061
550 EYE IRRITATION 352 0.0061
551 CHROMATURIA 138 0.0061
552 HAEMORRHOIDS 119 0.0061
553 ACUTE HEPATIC FAILURE 83 0.0061
554 ROTATOR CUFF SYNDROME 78 0.0061
555 PAIN IN JAW 172 0.0061
556 DIZZINESS 3014 0.0060
557 SPINAL DISORDER 57 0.0060
558 PLEURAL EFFUSION 366 0.0060
559 ADVERSE EVENT 554 0.0060
560 PULMONARY HYPERTENSION 125 0.0060
561 LIMB INJURY 163 0.0060
562 LYMPHADENOPATHY 212 0.0060
563 OBSESSIVE-COMPULSIVE DISORDER 48 0.0060
564 TOOTHACHE 108 0.0060
565 LACRIMATION INCREASED 180 0.0060
566 RENAL PAIN 63 0.0059
567 PETECHIAE 62 0.0059
568 BLOOD ALBUMIN DECREASED 47 0.0059
569 KIDNEY INFECTION 116 0.0059
570 ANAPHYLACTIC REACTION 326 0.0059
571 PULMONARY EMBOLISM 560 0.0059
572 DECUBITUS ULCER 48 0.0059
573 BRONCHOSPASM 84 0.0059
574 DEPRESSED MOOD 311 0.0059
575 HAEMATEMESIS 149 0.0059
576 SKIN HAEMORRHAGE 87 0.0059
577 VIRAL INFECTION 195 0.0059
578 ELECTROLYTE IMBALANCE 68 0.0058
579 PANCYTOPENIA 327 0.0058
580 DYSPHAGIA 555 0.0058
581 DECREASED ACTIVITY 63 0.0058
582 SEPSIS 649 0.0058
583 BLOOD COUNT ABNORMAL 88 0.0058
584 ENCEPHALOPATHY 142 0.0058
585 MUSCLE SPASTICITY 71 0.0058
586 ASTHENIA 2172 0.0058
587 PERIPHERAL COLDNESS 79 0.0057
588 HYPOGLYCAEMIA 279 0.0057
589 TENDON RUPTURE 71 0.0057
590 LIMB DISCOMFORT 177 0.0057
591 TEMPERATURE INTOLERANCE 59 0.0057
592 PSORIASIS 745 0.0057
593 IMPAIRED QUALITY OF LIFE 82 0.0057
594 OVARIAN CYST 57 0.0057
595 CHOLELITHIASIS 187 0.0057
596 BLOOD POTASSIUM DECREASED 171 0.0057
597 INCONTINENCE 60 0.0057
598 IMMUNOSUPPRESSION 50 0.0057
599 SNEEZING 127 0.0057
600 OFF LABEL USE 4947 0.0056
601 ACNE 428 0.0056
602 RENAL IMPAIRMENT 474 0.0056
603 VENTRICULAR TACHYCARDIA 93 0.0056
604 PNEUMONITIS 153 0.0056
605 WRIST FRACTURE 67 0.0056
606 OCULAR HYPERAEMIA 265 0.0056
607 THERAPEUTIC RESPONSE DECREASED 338 0.0056
608 PAIN OF SKIN 150 0.0056
609 DISEASE RECURRENCE 265 0.0056
610 BLOOD SODIUM DECREASED 105 0.0056
611 RESPIRATORY FAILURE 406 0.0056
612 ERYTHEMA 1144 0.0056
613 GALLBLADDER DISORDER 99 0.0055
614 URINARY TRACT INFECTION 944 0.0055
615 RASH PAPULAR 124 0.0055
616 CHILLS 645 0.0055
617 HOSPICE CARE 54 0.0055
618 GOUT 98 0.0055
619 PULMONARY CONGESTION 72 0.0055
620 DEFORMITY 51 0.0055
621 CYSTITIS 173 0.0054
622 ORAL HERPES 106 0.0054
623 NEURALGIA 132 0.0054
624 DIPLOPIA 140 0.0054
625 ASPIRATION 59 0.0054
626 SPINAL PAIN 63 0.0054
627 ECZEMA 281 0.0054
628 NEUTROPENIA 730 0.0054
629 URINARY INCONTINENCE 159 0.0054
630 ANKLE FRACTURE 83 0.0054
631 EPISTAXIS 401 0.0054
632 INITIAL INSOMNIA 55 0.0054
633 PNEUMOTHORAX 85 0.0054
634 BLOOD ALKALINE PHOSPHATASE INCREASED 133 0.0054
635 SEPTIC SHOCK 233 0.0053
636 SUICIDAL IDEATION 488 0.0053
637 NERVE COMPRESSION 49 0.0053
638 HALLUCINATION, VISUAL 112 0.0053
639 OXYGEN SATURATION DECREASED 298 0.0053
640 MENTAL STATUS CHANGES 147 0.0053
641 PHARYNGEAL OEDEMA 81 0.0053
642 BURNING SENSATION 368 0.0052
643 BLOOD CALCIUM DECREASED 59 0.0052
644 NASAL CONGESTION 308 0.0052
645 COVID-19 917 0.0052
646 ORTHOSTATIC HYPOTENSION 91 0.0052
647 BACK PAIN 1211 0.0052
648 GLOMERULAR FILTRATION RATE DECREASED 64 0.0052
649 HEPATIC STEATOSIS 97 0.0052
650 SYNCOPE 520 0.0052
651 HEPATOMEGALY 51 0.0052
652 ABDOMINAL PAIN LOWER 131 0.0052
653 PRODUCT DISTRIBUTION ISSUE 48 0.0052
654 APHONIA 72 0.0052
655 DIZZINESS POSTURAL 50 0.0052
656 PANIC ATTACK 187 0.0051
657 HYPERBILIRUBINAEMIA 53 0.0051
658 ALANINE AMINOTRANSFERASE INCREASED 314 0.0051
659 MULTIPLE FRACTURES 84 0.0051
660 HAEMATURIA 175 0.0051
661 SECRETION DISCHARGE 64 0.0051
662 ORAL DISCOMFORT 71 0.0051
663 THROAT TIGHTNESS 138 0.0051
664 HYPERSOMNIA 146 0.0051
665 HYPOPHAGIA 130 0.0051
666 LETHARGY 292 0.0051
667 SINUS BRADYCARDIA 49 0.0051
668 HAIR COLOUR CHANGES 63 0.0051
669 PRESYNCOPE 123 0.0051
670 FLUID RETENTION 257 0.0050
671 NERVE INJURY 56 0.0050
672 RETCHING 107 0.0050
673 MYALGIA 851 0.0050
674 DEVICE RELATED INFECTION 77 0.0050
675 OSTEONECROSIS OF JAW 123 0.0050
676 TOOTH LOSS 103 0.0050
677 AGRANULOCYTOSIS 92 0.0049
678 INFLUENZA 551 0.0049
679 HYPONATRAEMIA 278 0.0049
680 FAECES DISCOLOURED 107 0.0049
681 IMMUNE SYSTEM DISORDER 65 0.0049
682 BLOOD PRESSURE SYSTOLIC INCREASED 96 0.0049
683 RASH GENERALISED 127 0.0049
684 HAEMATOCRIT DECREASED 97 0.0049
685 HERPES ZOSTER 281 0.0049
686 NEUTROPHIL COUNT INCREASED 50 0.0049
687 FEELING JITTERY 93 0.0049
688 FEAR 131 0.0049
689 ASCITES 143 0.0049
690 COAGULOPATHY 81 0.0049
691 TRANSAMINASES INCREASED 108 0.0049
692 DYSPHONIA 284 0.0049
693 TACHYPNOEA 66 0.0048
694 TREATMENT NONCOMPLIANCE 265 0.0048
695 DEHYDRATION 646 0.0048
696 POOR VENOUS ACCESS 50 0.0048
697 MUCOSAL INFLAMMATION 125 0.0048
698 PALPITATIONS 555 0.0047
699 POOR QUALITY SLEEP 102 0.0047
700 HEART RATE IRREGULAR 107 0.0047
701 PRODUCT PRESCRIBING ISSUE 103 0.0047
702 ASPARTATE AMINOTRANSFERASE INCREASED 251 0.0047
703 VENTRICULAR EXTRASYSTOLES 49 0.0047
704 POLLAKIURIA 196 0.0047
705 DISEASE PROGRESSION 555 0.0047
706 CARDIAC FAILURE CONGESTIVE 375 0.0047
707 HAEMATOMA 120 0.0046
708 AGEUSIA 115 0.0046
709 VISION BLURRED 632 0.0046
710 PRODUCT ADMINISTRATION ERROR 93 0.0046
711 PRODUCT DOSE OMISSION IN ERROR 130 0.0046
712 SINUS TACHYCARDIA 65 0.0046
713 SKIN DISCOLOURATION 209 0.0045
714 LEUKOPENIA 226 0.0045
715 POLYNEUROPATHY 54 0.0045
716 CONSTIPATION 982 0.0045
717 DRY SKIN 600 0.0045
718 HEPATOTOXICITY 100 0.0045
719 HALLUCINATION 337 0.0045
720 PARANOIA 77 0.0045
721 GENERALISED OEDEMA 55 0.0044
722 HYPOCALCAEMIA 84 0.0044
723 ABDOMINAL DISTENSION 462 0.0044
724 BLOOD PRESSURE FLUCTUATION 106 0.0044
725 THROAT IRRITATION 198 0.0044
726 PALLOR 120 0.0044
727 CATARACT 262 0.0044
728 NIGHTMARE 152 0.0044
729 SHOCK 101 0.0044
730 HYPOTHYROIDISM 140 0.0044
731 SURGERY 256 0.0044
732 SKIN CANCER 94 0.0044
733 NEPHROPATHY TOXIC 49 0.0044
734 CHOLECYSTITIS 52 0.0044
735 HYPERTHYROIDISM 63 0.0043
736 RESPIRATORY DISTRESS 120 0.0043
737 PULMONARY OEDEMA 194 0.0043
738 POST PROCEDURAL COMPLICATION 83 0.0043
739 ABORTION SPONTANEOUS 173 0.0043
740 LUNG INFECTION 67 0.0043
741 UNDERDOSE 314 0.0043
742 HYPOTENSION 862 0.0043
743 SPINAL FRACTURE 86 0.0043
744 ANOSMIA 62 0.0043
745 PERICARDIAL EFFUSION 99 0.0043
746 ANGIOEDEMA 189 0.0043
747 GASTROINTESTINAL PAIN 47 0.0043
748 UPPER LIMB FRACTURE 85 0.0043
749 MUSCLE ATROPHY 54 0.0043
750 FLUID OVERLOAD 62 0.0043
751 HYPOAESTHESIA ORAL 64 0.0042
752 SARS-COV-2 TEST POSITIVE 56 0.0042
753 HAEMATOCHEZIA 234 0.0042
754 THROMBOSIS 341 0.0042
755 RED BLOOD CELL COUNT DECREASED 121 0.0042
756 HEART RATE INCREASED 419 0.0042
757 EYE PRURITUS 142 0.0042
758 IMPAIRED DRIVING ABILITY 48 0.0042
759 FULL BLOOD COUNT DECREASED 85 0.0042
760 TREMOR 699 0.0042
761 BALANCE DISORDER 364 0.0042
762 FEELING COLD 117 0.0042
763 INTERNAL HAEMORRHAGE 48 0.0042
764 VERTIGO 256 0.0042
765 TOOTH DISORDER 93 0.0042
766 DRUG INEFFECTIVE 5492 0.0042
767 BLOOD URINE PRESENT 79 0.0042
768 MELAENA 91 0.0041
769 EATING DISORDER 88 0.0041
770 INTERSTITIAL LUNG DISEASE 200 0.0041
771 EYELID OEDEMA 48 0.0041
772 BLOOD UREA INCREASED 69 0.0041
773 HIP FRACTURE 132 0.0041
774 LYMPHOPENIA 58 0.0041
775 PLATELET COUNT INCREASED 53 0.0041
776 BONE PAIN 238 0.0041
777 ELECTROCARDIOGRAM QT PROLONGED 146 0.0041
778 GINGIVAL BLEEDING 55 0.0040
779 MIDDLE INSOMNIA 75 0.0040
780 COLITIS 152 0.0040
781 ACTIVITIES OF DAILY LIVING IMPAIRED 79 0.0040
782 PRODUCT DOSE OMISSION ISSUE 1172 0.0040
783 SPINAL OPERATION 49 0.0040
784 COLD SWEAT 70 0.0040
785 INTENTIONAL DOSE OMISSION 113 0.0040
786 HEAD INJURY 125 0.0039
787 BONE LOSS 59 0.0039
788 DIABETES MELLITUS 299 0.0039
789 MUSCLE TWITCHING 90 0.0039
790 LYMPHOCYTE COUNT DECREASED 69 0.0039
791 BONE MARROW FAILURE 79 0.0039
792 HAIR TEXTURE ABNORMAL 52 0.0039
793 BLOOD PRESSURE ABNORMAL 77 0.0039
794 EJECTION FRACTION DECREASED 60 0.0039
795 BLOOD CREATININE INCREASED 250 0.0038
796 MUSCLE TIGHTNESS 62 0.0038
797 HYPERKALAEMIA 134 0.0038
798 RENAL FAILURE ACUTE 162 0.0038
799 CIRCULATORY COLLAPSE 65 0.0038
800 GENITAL HAEMORRHAGE 49 0.0038
801 HEPATOCELLULAR INJURY 54 0.0038
802 DRUG LEVEL INCREASED 63 0.0038
803 SENSORY DISTURBANCE 61 0.0038
804 GLAUCOMA 73 0.0038
805 DYSSTASIA 110 0.0038
806 LOSS OF CONSCIOUSNESS 482 0.0038
807 RENAL DISORDER 175 0.0038
808 INTENTIONAL PRODUCT MISUSE 327 0.0037
809 MOOD SWINGS 119 0.0037
810 FALL 1242 0.0037
811 HYPERHIDROSIS 479 0.0037
812 BLOOD PRESSURE INCREASED 568 0.0037
813 HAEMOGLOBIN DECREASED 381 0.0037
814 HOT FLUSH 279 0.0037
815 PRODUCT USE COMPLAINT 58 0.0037
816 PROCEDURAL PAIN 102 0.0037
817 GASTRIC DISORDER 126 0.0037
818 DISTURBANCE IN ATTENTION 198 0.0037
819 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 660 0.0037
820 CRYING 133 0.0037
821 BLINDNESS 149 0.0037
822 EYE DISORDER 120 0.0036
823 HYPOACUSIS 157 0.0036
824 SEROTONIN SYNDROME 70 0.0036
825 PSYCHOTIC DISORDER 107 0.0036
826 BLOOD TRIGLYCERIDES INCREASED 64 0.0036
827 DYSARTHRIA 136 0.0036
828 UNEVALUABLE EVENT 271 0.0036
829 FACE OEDEMA 60 0.0036
830 IMPAIRED WORK ABILITY 76 0.0036
831 RESTLESSNESS 130 0.0035
832 DISSEMINATED INTRAVASCULAR COAGULATION 50 0.0035
833 HALLUCINATION, AUDITORY 56 0.0035
834 DERMATITIS ATOPIC 185 0.0035
835 MENTAL IMPAIRMENT 85 0.0035
836 ERECTILE DYSFUNCTION 90 0.0035
837 CORONARY ARTERY OCCLUSION 48 0.0035
838 MOVEMENT DISORDER 112 0.0035
839 THIRST 62 0.0035
840 ARRHYTHMIA 164 0.0035
841 BLOOD POTASSIUM INCREASED 56 0.0034
842 URINARY RETENTION 115 0.0034
843 HEART RATE DECREASED 121 0.0034
844 LOCAL SWELLING 60 0.0034
845 THERAPEUTIC RESPONSE UNEXPECTED 154 0.0034
846 GASTROENTERITIS 50 0.0034
847 SUBDURAL HAEMATOMA 49 0.0034
848 PRURITUS GENERALISED 74 0.0034
849 HERNIA 66 0.0034
850 PNEUMONIA ASPIRATION 85 0.0034
851 FEEDING DISORDER 69 0.0034
852 BLOOD PRESSURE DECREASED 226 0.0034
853 FLATULENCE 192 0.0034
854 FEELING ABNORMAL 805 0.0034
855 GASTROINTESTINAL HAEMORRHAGE 280 0.0033
856 DYSKINESIA 136 0.0033
857 MOOD ALTERED 91 0.0033
858 BLOOD BILIRUBIN INCREASED 90 0.0033
859 HOSPITALISATION 509 0.0033
860 WHITE BLOOD CELL COUNT DECREASED 359 0.0033
861 NEUROTOXICITY 58 0.0033
862 THYROID DISORDER 51 0.0033
863 SPEECH DISORDER 172 0.0033
864 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 96 0.0033
865 FLUSHING 331 0.0033
866 SKIN BURNING SENSATION 233 0.0032
867 HEPATIC FAILURE 98 0.0032
868 METABOLIC ACIDOSIS 103 0.0032
869 COGNITIVE DISORDER 150 0.0032
870 MENTAL DISORDER 139 0.0032
871 ANGINA PECTORIS 90 0.0031
872 PLATELET COUNT DECREASED 334 0.0031
873 DISORIENTATION 124 0.0031
874 SKIN IRRITATION 143 0.0031
875 CARDIAC FAILURE 249 0.0031
876 MUSCULOSKELETAL DISORDER 59 0.0031
877 UNRESPONSIVE TO STIMULI 80 0.0031
878 SOMNOLENCE 621 0.0031
879 MULTI-ORGAN FAILURE 53 0.0031
880 VAGINAL HAEMORRHAGE 133 0.0031
881 NERVOUSNESS 160 0.0031
882 LACTIC ACIDOSIS 99 0.0031
883 INTESTINAL OBSTRUCTION 115 0.0030
884 PLASMA CELL MYELOMA 118 0.0030
885 METASTASES TO LIVER 53 0.0030
886 OSTEONECROSIS 99 0.0030
887 FRACTURE 57 0.0030
888 DYSGEUSIA 223 0.0030
889 AGITATION 220 0.0030
890 HYPERGLYCAEMIA 107 0.0029
891 IRRITABILITY 176 0.0029
892 EMOTIONAL DISORDER 90 0.0029
893 CARDIAC ARREST 241 0.0029
894 INFLUENZA LIKE ILLNESS 240 0.0029
895 THERAPY INTERRUPTED 206 0.0029
896 INCREASED APPETITE 55 0.0029
897 RHABDOMYOLYSIS 120 0.0029
898 THERAPEUTIC RESPONSE SHORTENED 95 0.0029
899 METASTASES TO BONE 47 0.0029
900 BRADYCARDIA 151 0.0028
901 DIABETES MELLITUS INADEQUATE CONTROL 50 0.0028
902 FEMUR FRACTURE 87 0.0028
903 ERUCTATION 54 0.0028
904 SUICIDE ATTEMPT 169 0.0028
905 PRODUCT DOSE OMISSION 181 0.0028
906 CHOKING 54 0.0028
907 CARDIAC DISORDER 258 0.0028
908 APHASIA 83 0.0027
909 ABNORMAL DREAMS 74 0.0027
910 ACUTE MYOCARDIAL INFARCTION 79 0.0027
911 BLOOD CREATINE PHOSPHOKINASE INCREASED 77 0.0027
912 THERAPY CESSATION 137 0.0027
913 DEVICE DISLOCATION 116 0.0027
914 CARDIO-RESPIRATORY ARREST 111 0.0027
915 DYSTONIA 51 0.0026
916 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58 0.0026
917 TARDIVE DYSKINESIA 73 0.0026
918 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 59 0.0025
919 CARDIOVASCULAR DISORDER 64 0.0025
920 INCORRECT PRODUCT ADMINISTRATION DURATION 54 0.0025
921 NEUTROPHIL COUNT DECREASED 101 0.0025
922 SEIZURE 285 0.0025
923 TOXICITY TO VARIOUS AGENTS 401 0.0024
924 PRODUCT AVAILABILITY ISSUE 54 0.0024
925 VISUAL ACUITY REDUCED 77 0.0023
926 CEREBRAL INFARCTION 56 0.0023
927 INTENTIONAL OVERDOSE 143 0.0022
928 NERVOUS SYSTEM DISORDER 69 0.0022
929 CONVULSION 126 0.0022
930 EXPOSURE VIA SKIN CONTACT 57 0.0022
931 NEEDLE ISSUE 63 0.0022
932 HEPATIC FUNCTION ABNORMAL 79 0.0021
933 SEDATION 55 0.0021
934 ACCIDENTAL OVERDOSE 76 0.0021
935 DEVICE BREAKAGE 84 0.0021
936 INJECTION SITE SWELLING 158 0.0021
937 MALIGNANT NEOPLASM PROGRESSION 210 0.0020
938 INJECTION SITE URTICARIA 49 0.0020
939 RESPIRATORY ARREST 55 0.0020
940 APPLICATION SITE ERYTHEMA 52 0.0020
941 GLYCOSYLATED HAEMOGLOBIN INCREASED 50 0.0020
942 MENSTRUATION IRREGULAR 52 0.0019
943 AGGRESSION 97 0.0019
944 ABASIA 47 0.0019
945 ABNORMAL BEHAVIOUR 75 0.0019
946 INJECTION SITE PRURITUS 126 0.0019
947 ANAPHYLACTIC SHOCK 48 0.0019
948 MYOCARDIAL INFARCTION 321 0.0018
949 COMPLETED SUICIDE 153 0.0018
950 FOETAL EXPOSURE DURING PREGNANCY 149 0.0018
951 DEMENTIA 51 0.0018
952 DEVICE ISSUE 163 0.0018
953 NEOPLASM PROGRESSION 62 0.0018
954 ANGER 60 0.0018
955 CEREBROVASCULAR ACCIDENT 298 0.0018
956 DEATH 1503 0.0017
957 INJECTION SITE BRUISING 138 0.0017
958 WITHDRAWAL SYNDROME 72 0.0017
959 PRODUCT SUBSTITUTION ISSUE 98 0.0017
960 DRUG ADMINISTRATION ERROR 51 0.0017
961 PRODUCT QUALITY ISSUE 225 0.0017
962 OVERDOSE 357 0.0017
963 INJECTION SITE ERYTHEMA 203 0.0016
964 MULTIPLE SCLEROSIS 78 0.0016
965 LUNG NEOPLASM MALIGNANT 67 0.0016
966 INJECTION SITE PAIN 498 0.0016
967 INJECTION SITE REACTION 110 0.0016
968 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 322 0.0016
969 BLOOD GLUCOSE INCREASED 299 0.0016
970 INJECTION SITE MASS 58 0.0016
971 INJECTION SITE RASH 48 0.0016
972 NO ADVERSE EVENT 281 0.0015
973 INCORRECT DOSE ADMINISTERED 353 0.0015
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 108 0.0015
975 BLOOD GLUCOSE DECREASED 71 0.0015
976 DRUG DOSE OMISSION 241 0.0015
977 NEOPLASM MALIGNANT 94 0.0014
978 DEPRESSED LEVEL OF CONSCIOUSNESS 55 0.0014
979 PRODUCT STORAGE ERROR 119 0.0014
980 DRUG ABUSE 113 0.0014
981 DRUG EFFECT DECREASED 69 0.0013
982 DEVICE MALFUNCTION 83 0.0012
983 EXTRA DOSE ADMINISTERED 47 0.0012
984 MULTIPLE SCLEROSIS RELAPSE 78 0.0011
985 ACCIDENTAL EXPOSURE TO PRODUCT 114 0.0011
986 INJECTION SITE HAEMORRHAGE 84 0.0011
987 COMA 50 0.0010
988 DRUG WITHDRAWAL SYNDROME 84 0.0010
989 DRUG DEPENDENCE 147 0.0009
990 DEVICE DIFFICULT TO USE 51 0.0008
991 BREAST CANCER 54 0.0006